Article
Association of PDGFRB, VEGFR2, and TGFB1 Gene Polymorphisms with Nintedanib Efficacy and Adverse Effects in Patients with Progressive Pulmonary Fibrosis.
International journal of molecular sciences - 23 Aug 2026
Djurdjevic Natasa, Pjevic Marija Dusanović, Stjepanovic Mihailo, Colic Nikola, Dimic-Janjic Sanja, Jankovic Jelena, Maric Nikola, Zecevic Andrej, Terzic Milica, Golubovic Aleksa, Milivojevic Ivan, Omcikus Maja, Ilic Branislav, Lukic Katarina, Mijatovic Snjezana, Grk Milka
Abstract excerpt
Progressive pulmonary fibrosis (PPF) comprises interstitial lung diseases characterized by progressive fibrosis and lung function decline. Nintedanib slows disease progression by inhibiting FGFR, VEGFR, and PDGFR signaling, but treatment response varies among patients. We investigated whether VEGFR2, PDGFRB, and TGFB1 gene variants are associated with nintedanib treatment outcomes, including changes in pulmonary...
Read the complete abstract on PubMedTopics
- Humans
- Transforming Growth Factor beta1
- Female
- Male
